Home / Psoriasis (page 23)


Here you will find the latest clinical research on psoriasis.

Safety and Efficacy of Secukinumab in Mild Psoriasis

  Purpose Mild psoriasis not only progresses to moderate-to-severe psoriasis but also precedes systemic inflammation that leads to psoriatic arthritis and cardiovascular comorbidities. By curing mild psoriasis with a short-term anti- interleukin (IL)-17A treatment, investigators may reduce the costs of treating psoriasis and associated medical conditions, including psoriatic arthritis, cardiovascular …

Read More »

A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp (STYLE)

  Purpose This is a Phase 3, multicenter, randomized, placebo-controlled, double-blind study of the efficacy and safety of apremilast (CC-10004) in subjects with moderate to severe plaque psoriasis of the scalp. Approximately 300 subjects with moderate to severe plaque psoriasis of the scalp will be randomized 2:1 to receive either …

Read More »

Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS

  Purpose An Open Label, Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment with DSXS . Condition Intervention Phase Psoriasis Drug: DSXS Topical product Phase 2 Study Type: Interventional Study Design: Intervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment Official Title: An Open-Label, …

Read More »

Potential Research Study Participant Registry

  Purpose The purpose of the potential research study participant registry is to keep potential research subjects informed about any future research studies in which they may meet the criteria for enrollment. The purpose of this study is also to assist current and future clinical trials with recruitment of subjects. …

Read More »

A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis

  Purpose The primary purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) by assessing the reduction in signs and symptoms of PsA. Condition Intervention Phase Arthritis, Psoriatic Drug: Guselkumab Drug: Placebo Phase 3 Study Type: Interventional Study Design: Allocation: …

Read More »

Biologics Anchoring Study

  Purpose Biologics are used to treat conditions such as moderate-to-severe psoriasis, a chronic condition that impairs quality of life as much or more than other major medical conditions. Biopharmaceuticals are medications which are are isolated from biological sources including microorganisms, animals or humans. These medications generally function to decrease …

Read More »

Secukinumab effective for moderate to severe scalp psoriasis


FROM THE JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY Secukinumab is a safe and effective treatment option for patients with moderate to severe scalp psoriasis, according to Dr. Jerry Bagel of the Psoriasis Treatment Center of Central New Jersey, and his associates.  After 12 weeks of treatment with 300 mg …

Read More »

OWCP and mediq Collaborate to Introduce Cannabinoid-based Psoriasis Cream

marijuana Psoriasis

One World Cannabis Pharmaceutical Research (OWCP) and mediq Innovation Experts have partnered to introduce OWCP’s cannabinoid-based topical psoriasis cream in Germany. Germany-based mediq has extensive experience in assisting companies based in Israel enter European markets. Under the new agreement, mediq will support OWCP with both a scientific collaboration and in marketing …

Read More »